Select area to zoom
Created with Highcharts 11.1.0Jul '24Oct '24Jan '25Apr '2520.001.29

Profile

Edit
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
URL https://www.pliantrx.com
Investor Relations URL https://ir.pliantrx.com/
HQ State/Province California
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release Aug. 07, 2025 (est.)
Last Earnings Release May. 08, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Edit
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
URL https://www.pliantrx.com
Investor Relations URL https://ir.pliantrx.com/
HQ State/Province California
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release Aug. 07, 2025 (est.)
Last Earnings Release May. 08, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A
Quickflows